Known to the industry as “sudden unintended acceleration,” the question for regulators is whether the problem is a human one or an engineering one, and over the years, engineers who think they’ve ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
Abstract: The Multiple Longest Common Subsequence (MLCS) Problem is to find one or more longest common subsequences from multiple (≥ 3) strings. However, as the scale of the sequences increases, the ...